Risk-adapted strategy for the management of febrile neutropenia in cancer patients

被引：0
|
作者：
Jean Klastersky
Marianne Paesmans
机构：
[1] Oncology Program for the Brussels Public Hospitals (PSOM),Institut Jules Bordet
[2] Institut Jules Bordet,Data Centre
来源：
Supportive Care in Cancer | 2007年 / 15卷
关键词：
Febrile neutropenia; Sepsis; Antifungal therapy; Risk prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：477 / 482
页数：5
相关论文
共 50 条
  • [1] Risk-adapted strategy for the management of febrile neutropenia in cancer patients
    Klastersky, Jean
    Paesmans, Marianne
    SUPPORTIVE CARE IN CANCER, 2007, 15 (05) : 477 - 482
  • [2] RISK-ADAPTED APPROACH FOR FEVER AND NEUTROPENIA IN PEDIATRIC CANCER PATIENTS
    Miedema, Karin
    Tissing, Wim
    Abbink, Floor
    Ball, Lynn
    Michiels, Erna
    Norbruis, Obbe
    van de Wetering, Marianne
    de Groot-Kruseman, Hester
    de Bont, Eveline
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1007 - 1007
  • [3] Radiation therapy in prostate cancer: a risk-adapted strategy
    Hayden, A. J.
    Catton, C.
    Pickles, T.
    CURRENT ONCOLOGY, 2010, 17 : S18 - S24
  • [4] Risk-adapted approach for fever and neutropenia in paediatric cancer patients e A national multicentre study
    Miedema, Karin G. E.
    Tissing, Wim J. E.
    Abbink, Floor C. H.
    Ball, Lynne M.
    Michiels, Erna M. C.
    van Vliet, Michel J.
    de Vries, Wilma Y.
    Kamps, Willem A.
    Norbruis, Obbe F.
    Fiocco, Marta
    de Groot-Kruseman, Hester A.
    van de Wetering, Marianne D.
    de Bont, Eveline S. J. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 53 : 16 - 24
  • [5] Is It Time for Early Cessation of Empirical Antibiotherapy in Patients Presenting with Febrile Neutropenia? Preliminary Results of a Risk-Adapted Approach in a Hematology Clinic
    Kaya, Ali Hakan
    Tekgunduz, Emre
    Bekdemir, Filiz
    Batgi, Hikmetullah
    Yigenoglu, Tugcenur
    Ulu, Bahar Uncu
    Ugur, Bilge
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Akpinar, Seval
    Demirkan, Fatih
    Altuntas, Fevzi
    BLOOD, 2016, 128 (22)
  • [6] Evaluation and management of febrile neutropenia in patients with cancer
    Cossey, Jason
    Cote, Mary Claire B.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (08): : 16 - 20
  • [7] Risk-adapted Treatment Strategy For COVID-19 Patients
    Zheng, Changcheng
    Wang, Jinquan
    Guo, Hui
    Lu, Zhaohui
    Ma, Yan
    Zhu, Yuyou
    Xia, Daqing
    Wang, Yinzhong
    He, Hongliang
    Zhou, Jian
    Wang, Yong
    Fei, Mingming
    Yin, Yihong
    Zheng, Mao
    Xu, Yehong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 94 : 74 - 77
  • [8] Management of infection and febrile neutropenia in patients with solid cancer
    J. A. Virizuela
    J. Carratalà
    J. M. Aguado
    D. Vicente
    M. Salavert
    M. Ruiz
    I. Ruiz
    F. Marco
    M. Lizasoain
    P. Jiménez-Fonseca
    C. Gudiol
    J. Cassinello
    A. Carmona-Bayonas
    M. Aguilar
    J. J. Cruz
    Clinical and Translational Oncology, 2016, 18 : 557 - 570
  • [9] Management of Infection and Febrile Neutropenia in Patients with Solid Cancer
    Maria Aguado, Jose
    Jesus Cruz, Juan
    Antonio Virizuela, Juan
    Aguilar, Manuela
    Carmona, Alberto
    Cassinello, Javier
    Gudiol, Carlota
    Jimenez Fonseca, Paula
    Lizasoain, Manuel
    Marco, Francesc
    Ruiz, Isabel
    Ruiz, Maribel
    Salavert, Miguel
    Vicente, David
    Carratala, Jordi
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (07): : 451 - 460
  • [10] Risk-adapted management of pulmonary embolism
    Barco, Stefano
    Konstantinides, Stavros V.
    THROMBOSIS RESEARCH, 2017, 151 : S92 - S96
12345